Home » Stocks » Pulse Biosciences

Pulse Biosciences, Inc. (PLSE)

Stock Price: $11.13 USD 0.35 (3.25%)
Updated Aug 7, 2020 4:00 PM EDT - Market closed
After-hours: $11.34 +0.21 (1.89%) Aug 7, 4:55 PM

Stock Price Chart

Key Info

Market Cap 279.91M
Revenue (ttm) n/a
Net Income (ttm) -48.77M
Shares Out 25.15M
EPS (ttm) -2.35
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 7, 2020
Last Price $11.13
Previous Close $10.78
Change ($) 0.35
Change (%) 3.25%
Day's Open 10.77
Day's Range 10.71 - 11.44
Day's Volume 55,985
52-Week Range 5.11 - 17.45

More Stats

Market Cap 279.91M
Enterprise Value 270.71M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 25.15M
Float 10.67M
EPS (basic) -2.35
EPS (diluted) -2.35
FCF / Share -1.79
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 2.73M
Short Ratio 25.17
Short % of Float 17.30%
Beta 2.02
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 13.26
Revenue n/a
Operating Income -49.49M
Net Income -48.77M
Free Cash Flow -37.21M
Net Cash 9.20M
Net Cash / Share 0.37
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -64.92%
ROE -120.58%
ROIC -162.30%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$16.00*
Low
16.0
Current: $11.13
High
16.0
Target: 16.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015
Revenue-----
Operating Income-47.95-37.96-25.81-9.59-4.47
Net Income-46.97-37.55-25.57-9.52-2.81
Shares Outstanding20.7517.0814.7511.017.57
Earnings Per Share-2.26-2.20-1.73-0.86-0.37
Operating Cash Flow-34.19-23.90-11.09-8.05-3.32
Capital Expenditures-0.61-0.28-2.55-0.06-0.09
Free Cash Flow-34.79-24.17-13.64-8.12-3.40
Cash & Equivalents25.4059.5838.0716.403.61
Total Debt6.72----
Net Cash / Debt18.6859.5838.0716.403.61
Assets41.9270.6449.8226.3114.33
Liabilities11.184.313.831.020.66
Book Value30.7466.3346.0025.3013.67
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Pulse Biosciences, Inc.
Country United States
Employees 82
CEO Darrin R. Uecker

Stock Information

Ticker Symbol PLSE
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NASDAQ: PLSE
IPO Date May 18, 2016

Description

Pulse Biosciences, Inc. operates as a clinical stage medical therapy company. It engages in the research and development, and commercialization of CellFX system that provides a precise and non-thermal cellular treatment technology delivering nanosecond duration energy pulses that impact cells in treated tissue while sparing surrounding non-cellular tissue primarily for dermatology applications. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was founded in 2014 and is headquartered in Hayward, California.